Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant

被引：2
|
作者：
Salem, R. [1 ,2 ]
Massoud, R. [1 ,2 ]
Haffar, B. [1 ,2 ]
Mahfouz, R. [3 ]
Bazarbachi, A. [1 ,2 ]
El-Cheikh, J. [1 ,2 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Div Hematol & Oncol, Dept Internal Med, Beirut, Lebanon
[3] Amer Univ Beirut, Dept Pathol & Lab Med, Beirut, Lebanon
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期
关键词：
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; NUCLEOPHOSMIN;
D O I：
10.1038/bmt.2017.82
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1187 / 1190
页数：4
相关论文
共 50 条
  • [41] Emberger Syndrome with Concomitant GATA2, NPM1 and FLT3-ITD Mutations in Remission after Allogeneic Stem Cell Transplant
    Saste, Abhijit Balkrishna
    Jiang, Feng
    Arias-Stella, Javier, III
    Gamalski, Steven
    Peres, Edward
    Janakiraman, Nalini
    Farhan, Shatha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S208 - S209
  • [42] THE IMPACT OF FLT3 MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: TYPE, SIZE AND INTERACTION WITH NPM1 MUTATIONS
    Tosic, N.
    Colovic, N.
    Colovic, M.
    Zukic, B.
    Pavlovic, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 456 - 456
  • [43] DETECTION OF NPM1 MUTATIONS IN AML PATIENTS
    Pazhakh, V.
    Zaker, F.
    Atashrazm, F.
    Razmkhah, F.
    Shahabi, E.
    Qaemi, P. Rasi
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 489 - 489
  • [44] Allogeneic stem cell transplantation for patients with AML and FLT-3 mutations
    Schleuning, M.
    Judith, D.
    Heshmat, M.
    Burlakova, I.
    Tschischka, S.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S274 - S275
  • [45] A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
    Huang, Qin
    Chen, Wengang
    Gaal, Karl K.
    Slovak, Marilyn L.
    Stein, Anthony
    Weiss, Lawrence M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (03) : 489 - 492
  • [46] Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?
    Lee, Sangmin
    Hsu, Jingmei
    Tahri, Yassine
    Chen, Zhengming
    Shore, Tsiporah B.
    Ritchie, Ellen K.
    Gergis, Usama
    Desai, Pinkal
    Mayer, Sebastian A.
    Samuel, Michael
    Phillips, Adrienne A.
    Cushing, Melissa M.
    Roboz, Gail J.
    Van Besien, Koen
    BLOOD, 2018, 132
  • [47] Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?
    Hsu, Jingmei
    Lee, Sangmin
    Tahri, Yassine
    Chen, Zhengming
    Shore, Tsiporah B.
    Gergis, Usama
    Mayer, Sebastian
    Phillips, Adrienne
    Ritchie, Ellen K.
    Desai, Pinkal
    Samuel, Michael
    Roboz, Gail
    van Besien, Koen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [48] PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS
    Green, C. L.
    Koo, K. K.
    Hills, R. K.
    Burnett, A. K.
    Linch, D. C.
    Gale, R. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 431 - 431
  • [49] Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation
    Khanolkar, Rutvij A.
    Faridi, Rehan M.
    Kinzel, Megan
    Jamani, Kareem
    Savoie, Mary L.
    Shafey, Mona
    Khan, Faisal M.
    Storek, Jan
    CYTOTHERAPY, 2022, 24 (04) : 413 - 420
  • [50] AML typical mutations ( CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
    Castano-Diez, Sandra
    Lopez-Guerra, Monica
    Zugasti, Ines
    Calvo, Xavier
    Schulz, Felicitas Isabel
    Avendano, Alejandro
    Mora, Elvira
    Falantes, Jose
    Azaceta, Gemma
    Ibanez, Mariam
    Chen, Tzu
    Notano, Cristina
    Amer, Neus
    Palomo, Laura
    Pomares, Helena
    Vila, Jordi
    del Castillo, Teresa Bernal
    Jimenez-Vicente, Carlos
    Esteban, Daniel
    Guijarro, Francesca
    Alamo, Jose
    Cortes-Bullich, Albert
    Torrecillas-Mayayo, Victor
    Triguero, Ana
    Mont-de Torres, Lucia
    Carcelero, Ester
    Cardus, Aina
    Germing, Ulrich
    Betz, Beate
    Rozman, Maria
    Arenillas, Leonor
    Zamora, Lurdes
    Diez-Campelo, Maria
    Xicoy, Blanca
    Esteve, Jordi
    Diaz-Bey, Marina
    BLOOD ADVANCES, 2025, 9 (01)
12345